ATLIX and Swiss m4m Center Announce Strategic Collaboration in Medical Additive Manufacturing

The partnership enhances industrial validation capabilities and advances regulated medical additive manufacturing through a close collaboration between a technology manufacturer and a leading European CDMO.

ATLIX and Swiss m4m Center, a premier Contract Development and Manufacturing Organization (CDMO) specialized in medical-grade additive manufacturing, have announced a strategic collaboration.

The partnership establishes a structured framework for technical and strategic cooperation, combining ATLIX’s expertise in industrial AM systems with Swiss m4m Center’s experience in regulated medical device manufacturing and process validation.

Through this collaboration, Swiss m4m Center will act as a reference industrial site for the evaluation and validation of ATLIX technologies within a regulated production setting. This enables the generation of high-quality process insights under real manufacturing conditions, supporting the continuous improvement of industrial AM applications for the medical sector.

In parallel, ATLIX will support Swiss m4m Center with prioritized access to new machine developments, technology updates, and early-stage evaluation programs, ensuring close alignment between machine innovation and industrial application requirements.

“This collaboration with Swiss m4m Center represents an recognition of ATLIX strong presence in the medical additive manufacturing Industry,” said Marino Ferrarese, ATLIX Head of Sales & Marketing. “By combining our industrial Additive Manufacturing expertise with a highly regulated production environment, we are able to further validate our technologies under real-world conditions and accelerate their adoption in critical applications where reliability and precision are essential.”

“By combining ATLIX’s machine precision and proven reliability with Swiss m4m Center’s expertise in regulated medical manufacturing, we ensure the production of medical devices with uncompromising performance, consistency, and trust,” said Nicolas Bouduban, CEO of Swiss m4m Center.

The partnership strengthens both organizations’ positions within the medical additive manufacturing ecosystem, enhancing technology validation capabilities, supporting industrial readiness, and reinforcing collaboration between machine development and regulated production environments.